Product Information
OXYCODONE-ACETAMINOPHEN 5-325 MG TAB is a generic product labeled by Alvogen Inc., priced at $0.1171 per EA under NDC 47781019601. Its NADAC has been published 532 times since Jul 27, 2016.
FDA first approved this application on Jul 26, 2012. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 5 mg/1; mg/1
Manufacturer
Alvogen Inc.NDC
47781019601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202677FDA Approved
7/26/2012
TE Code
AA
On Market Since
3/9/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TAB has been published 532 times since Jul 27, 2016, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1171 per EA |
|---|---|
| All-time high | $0.1562 (Sep 14, 2016) |
| All-time low | $0.0776 (May 20, 2020) |
| 52-week high | $0.1228 |
| 52-week low | $0.1171 |
| Median price | $0.1034 |
| Average price | $0.1052 |
| Largest weekly change | +13.9% (Feb 22, 2023) |
| Weeks tracked | 532 |
| Tracking since | Jul 27, 2016 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 5-325 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 5-325 MG TAB, manufactured by Alvogen Inc., is $0.1171 per EA (NDC 47781019601), effective Sep 30, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 5-325 MG TAB changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TAB has declined 15.1%. It has been tracked across 532 weekly CMS publications since Jul 27, 2016.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 5-325 MG TAB?
Since Jul 27, 2016, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TAB has ranged from a low of $0.0776 (May 20, 2020) to a high of $0.1562 (Sep 14, 2016), with a median of $0.1034 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 5-325 MG TAB?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.0864 per EA — about 26% below OXYCODONE-ACETAMINOPHEN 5-325 MG TAB.
Who manufactures OXYCODONE-ACETAMINOPHEN 5-325 MG TAB?
OXYCODONE-ACETAMINOPHEN 5-325 MG TAB (NDC 47781019601) is labeled by Alvogen Inc., and CMS classifies it as a generic product.